SCRM2027
3 - 4 May - Uppsala, Sweden
Abstract submission
Abstract submission deadline: December 11
Topics
- Beyond Cancer Treatment: Prevention, Survivorship, and the Future of Cancer Care
- Tumor Microenvironment & Immuno-Oncology: From Biology to Data-Driven Discovery
- Addressing Unmet Medical Needs
- Precision Medicine and Novel Therapeutics
Guidelines
TITLE: Spell out words, do not use abbreviations. The title or text is not to indicate the country of origin, unless it is pertinent to the topic.
AUTHORS: Names and surnames for each author must be provided. Do not include degrees or titles. Presenting authors’ name will be published in bold.
AFFILITATIONS: Each author should be listed by University/Hospital, Department and Country. Please make sure to include this complete information in the Affiliation text box.
TEXT: The abstract must be in English and should be a maximum of 300 words, excluding the title.
It is the author’s responsibility to submit a correct abstract; any errors in spelling, grammar, or scientific fact will be published as typed by the author, if accepted. Poor English may be a cause for rejection.
The Programme Committee will accept abstracts for the Scientific Programme (oral or poster presentation) on scientific merit.
Only Abstracts of registered participants will be printed. At least one of the authors must be registered for the Conference.
Abstractsupport
If you have any questions concerning your abstract submission, please contact abstracts+scrm2027@invajo.com
Important dates
Abstract submission deadline: December 11
Registration deadline: April 2

